In a subgroup analysis of patients with MASLD, at risk for advanced fibrosis (defined by having intermediate or high Fibrosis-4 Index or having co-occurring metabolic syndrome) was not associated with AST or ALT trend during pregnancy (AST: p = 0.71, ALT: p = 0.50). The gene discussed is GPT; the disease is metabolic syndrome.